Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1912 2
1913 2
1915 1
1917 1
1918 3
1920 1
1921 1
1924 3
1925 3
1928 4
1929 2
1930 2
1932 4
1934 1
1935 1
1938 1
1940 2
1941 1
1942 2
1944 1
1945 2
1946 5
1947 1
1948 3
1949 2
1955 2
1961 1
1962 2
1963 2
1964 1
1965 1
1966 1
1968 1
1970 4
1971 1
1972 2
1973 4
1974 5
1975 3
1976 6
1977 4
1978 6
1979 3
1980 4
1981 4
1982 3
1983 1
1984 2
1986 5
1987 2
1988 2
1989 2
1990 6
1991 2
1992 2
1993 3
1994 5
1995 7
1996 1
1997 1
1998 2
1999 1
2000 1
2001 1
2002 6
2003 2
2004 2
2005 10
2006 10
2007 6
2008 18
2009 9
2010 13
2011 26
2012 25
2013 28
2014 30
2015 31
2016 42
2017 37
2018 35
2019 28
2020 23
2021 34
2022 24
2023 32
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

592 results

Results by year

Filters applied: . Clear all
Page 1
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.
Klein EA, Richards D, Cohn A, Tummala M, Lapham R, Cosgrove D, Chung G, Clement J, Gao J, Hunkapiller N, Jamshidi A, Kurtzman KN, Seiden MV, Swanton C, Liu MC. Klein EA, et al. Among authors: cohn a. Ann Oncol. 2021 Sep;32(9):1167-1177. doi: 10.1016/j.annonc.2021.05.806. Epub 2021 Jun 24. Ann Oncol. 2021. PMID: 34176681 Free article.
Evaluation of cell-free DNA approaches for multi-cancer early detection.
Jamshidi A, Liu MC, Klein EA, Venn O, Hubbell E, Beausang JF, Gross S, Melton C, Fields AP, Liu Q, Zhang N, Fung ET, Kurtzman KN, Amini H, Betts C, Civello D, Freese P, Calef R, Davydov K, Fayzullina S, Hou C, Jiang R, Jung B, Tang S, Demas V, Newman J, Sakarya O, Scott E, Shenoy A, Shojaee S, Steffen KK, Nicula V, Chien TC, Bagaria S, Hunkapiller N, Desai M, Dong Z, Richards DA, Yeatman TJ, Cohn AL, Thiel DD, Berry DA, Tummala MK, McIntyre K, Sekeres MA, Bryce A, Aravanis AM, Seiden MV, Swanton C. Jamshidi A, et al. Among authors: cohn al. Cancer Cell. 2022 Dec 12;40(12):1537-1549.e12. doi: 10.1016/j.ccell.2022.10.022. Epub 2022 Nov 17. Cancer Cell. 2022. PMID: 36400018 Free article.
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer.
Makker V, Taylor MH, Aghajanian C, Oaknin A, Mier J, Cohn AL, Romeo M, Bratos R, Brose MS, DiSimone C, Messing M, Stepan DE, Dutcus CE, Wu J, Schmidt EV, Orlowski R, Sachdev P, Shumaker R, Casado Herraez A. Makker V, et al. Among authors: cohn al. J Clin Oncol. 2020 Sep 10;38(26):2981-2992. doi: 10.1200/JCO.19.02627. Epub 2020 Mar 13. J Clin Oncol. 2020. PMID: 32167863 Free PMC article. Clinical Trial.
Amanda Cohn Comments.
Cohn A. Cohn A. Am J Public Health. 2019 Dec;109(12):1717. doi: 10.2105/AJPH.2019.305387. Am J Public Health. 2019. PMID: 31693418 Free PMC article. No abstract available.
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, Ciuleanu TE, Portnoy DC, Van Cutsem E, Grothey A, Prausová J, Garcia-Alfonso P, Yamazaki K, Clingan PR, Lonardi S, Kim TW, Simms L, Chang SC, Nasroulah F; RAISE Study Investigators. Tabernero J, et al. Among authors: cohn al. Lancet Oncol. 2015 May;16(5):499-508. doi: 10.1016/S1470-2045(15)70127-0. Epub 2015 Apr 12. Lancet Oncol. 2015. PMID: 25877855 Clinical Trial.
Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.
Deputy NP, Deckert J, Chard AN, Sandberg N, Moulia DL, Barkley E, Dalton AF, Sweet C, Cohn AC, Little DR, Cohen AL, Sandmann D, Payne DC, Gerhart JL, Feldstein LR. Deputy NP, et al. Among authors: cohn ac. N Engl J Med. 2023 Jun 29;388(26):2434-2443. doi: 10.1056/NEJMoa2215201. Epub 2023 May 18. N Engl J Med. 2023. PMID: 37199451
Reply.
Gillies MC, Nguyen CL, Nguyen V, Daien V, Cohn A, Banerjee G, Arnold J; Fight Retinal Blindness! Study Group. Gillies MC, et al. Among authors: cohn a. Ophthalmology. 2020 Apr;127(4):e21-e22. doi: 10.1016/j.ophtha.2019.10.031. Ophthalmology. 2020. PMID: 32200844 No abstract available.
Revision Breast Augmentation.
Denney BD, Cohn AB, Bosworth JW, Kumbla PA. Denney BD, et al. Among authors: cohn ab. Semin Plast Surg. 2021 May;35(2):98-109. doi: 10.1055/s-0041-1727272. Epub 2021 Jun 8. Semin Plast Surg. 2021. PMID: 34121945 Free PMC article. Review.
Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial.
Makker V, Rasco D, Vogelzang NJ, Brose MS, Cohn AL, Mier J, Di Simone C, Hyman DM, Stepan DE, Dutcus CE, Schmidt EV, Guo M, Sachdev P, Shumaker R, Aghajanian C, Taylor M. Makker V, et al. Among authors: cohn al. Lancet Oncol. 2019 May;20(5):711-718. doi: 10.1016/S1470-2045(19)30020-8. Epub 2019 Mar 25. Lancet Oncol. 2019. PMID: 30922731 Clinical Trial.
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update.
Makker V, Aghajanian C, Cohn AL, Romeo M, Bratos R, Brose MS, Messing M, Dutta L, Dutcus CE, Huang J, Schmidt EV, Orlowski R, Taylor MH. Makker V, et al. Among authors: cohn al. J Clin Oncol. 2023 Feb 10;41(5):974-979. doi: 10.1200/JCO.22.01021. Epub 2023 Jan 6. J Clin Oncol. 2023. PMID: 36608305 Free PMC article. Clinical Trial.
592 results